40532 Federal Register / Vol. 83, No. 158 / Wednesday, August 15, 2018 / Notices 

eligible for benefits and services from 

the IHS. 

Recipients will be required to sign the 

HHS–690 Assurance of Compliance 

form which can be obtained from the 

following website: http://www.hhs.gov/ 

sites/default/files/forms/hhs-690.pdf, 

and send it directly to the: U.S. 

Department of Health and Human 

Services, Office of Civil Rights, 200 

Independence Ave. SW, Washington, 

DC 20201. 

E. Federal Awardee Performance and 

Integrity Information System (FAPIIS) 

The IHS is required to review and 

consider any information about the 

applicant that is in the Federal Awardee 

Performance and Integrity Information 

System (FAPIIS) before making any 

award in excess of the simplified 

acquisition threshold (currently 

$150,000) over the period of 

performance. An applicant may review 

and comment on any information about 

itself that a Federal awarding agency 

previously entered. IHS will consider 

any comments by the applicant, in 

addition to other information in FAPIIS 

in making a judgment about the 

applicant’s integrity, business ethics, 

and record of performance under 

Federal awards when completing the 

review of risk posed by applicants as 

described in 45 CFR 75.205. 

As required by 45 CFR part 75 

Appendix XII of the Uniform Guidance, 

non-federal entities (NFEs) are required 

to disclose in FAPIIS any information 

about criminal, civil, and administrative 

proceedings, and/or affirm that there is 

no new information to provide. This 

applies to NFEs that receive Federal 

awards (currently active grants, 

cooperative agreements, and 

procurement contracts) greater than 

$10,000,000 for any period of time 

during the period of performance of an 

award/project. 

Mandatory Disclosure Requirements 

As required by 2 CFR part 200 of the 

Uniform Guidance, and the HHS 

implementing regulations at 45 CFR part 

75, effective January 1, 2016, the IHS 

must require a non-Federal entity or an 

applicant for a Federal award to 

disclose, in a timely manner, in writing 

to the IHS or pass-through entity all 

violations of Federal criminal law 

involving fraud, bribery, or gratuity 

violations potentially affecting the 

Federal award. 

Submission is required for all 

applicants and recipients, in writing, to 

the IHS and to the HHS Office of 

Inspector General all information 

related to violations of Federal criminal 

law involving fraud, bribery, or gratuity 

violations potentially affecting the 

Federal award. 45 CFR 75.113. 

Disclosures must be sent in writing to: 

U.S. Department of Health and Human 

Services, Indian Health Service, 

Division of Grants Management, ATTN: 

Robert Tarwater, Director, 5600 Fishers 

Lane, Mail Stop: 09E70, Rockville, MD 

20857. 

(Include ‘‘Mandatory Grant 

Disclosures’’ in subject line) 

Office: (301) 443–5204. 

Fax: (301) 594–0899. 

Email: Robert.Tarwater@ihs.gov. 

AND 

U.S. Department of Health and 

Human Services, Office of Inspector 

General, ATTN: Mandatory Grant 

Disclosures, Intake Coordinator, 330 

Independence Avenue SW, Cohen 

Building, Room 5527, Washington, DC 

20201, URL: http://oig.hhs.gov/fraud/ 

report-fraud/index.asp. 

(Include ‘‘Mandatory Grant 

Disclosures’’ in subject line) 

Fax: (202) 205–0604 (Include 

‘‘Mandatory Grant Disclosures’’ in 

subject line) or 

Email: 

MandatoryGranteeDisclosures@

oig.hhs.gov. 

Failure to make required disclosures 

can result in any of the remedies 

described in 45 CFR 75.371. Remedies 

for noncompliance, including 

suspension or debarment (See 2 CFR 

parts 180 and 376 and 31 U.S.C. 3321). 

VII. Agency Contacts 

1. Questions on the programmatic 

issues may be directed to: Lisa C. Neel, 

Public Health Advisor, Office of Public 

Health Support, Division of 

Epidemiology & Disease Prevention, 

Indian Health Service, 5600 Fishers 

Lane, Mailstop: 09E17B, Rockville, MD 

20857, Phone: (301) 443–4305, EMail: 

Lisa.Neel@ihs.gov. 

2. Questions on grants management 

and fiscal matters may be directed to: 

John Hoffman, Senior Grants 

Management Specialist, 5600 Fishers 

Lane, Mail Stop: 09E70, Rockville, MD 

20857, Phone: (301) 443–2116, Fax: 

(301) 594–0899, Email: John.Hoffman@

ihs.gov. 

3. Questions on systems matters may 

be directed to: Paul Gettys, Grant 

Systems Coordinator, 5600 Fishers 

Lane, Mail Stop: 09E70, Rockville, MD 

20857, Phone: (301) 443–2114; or the 

DGM main line (301) 443–5204, Fax: 

(301) 594–0899, EMail: Paul.Gettys@

ihs.gov. 

VIII. Other Information 

The Public Health Service strongly 

encourages all cooperative agreement 

and contract recipients to provide a 

smoke-free workplace and promote the 

non-use of all tobacco products. In 

addition, Public Law 103–227, the ProChildren Act of 1994, prohibits smoking 

in certain facilities (or in some cases, 

any portion of the facility) in which 

regular or routine education, library, 

day care, health care, or early childhood 

development services are provided to 

children. This is consistent with the 

HHS mission to protect and advance the 

physical and mental health of the 

American people. 

Dated: August 9, 2018. 

Michael D. Weahkee, 

Assistant Surgeon General, U.S. Public Health 

Service, Acting Director, Indian Health 

Service. 

[FR Doc. 2018–17515 Filed 8–14–18; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Division of Epidemiology and Disease 

Prevention; Epidemiology Program for 

American Indian/Alaska Native Tribes 

and Urban Indian Communities 

Announcement Type: Competing 

Supplement 

Funding Announcement Number: HHS– 

2018–IHS–EPI–0001 

Catalog of Federal Domestic Assistance 

Number: 93.231 

Key Dates 

Application Deadline Date: September 

12, 2018 

Review Date: September 14–18, 2018 

Earliest Anticipated Start Date: 

September 30, 2018 

I. Funding Opportunity Description 

Statutory Authority 

The Indian Health Service (IHS) 

Office of Public Health Support, 

Division of Epidemiology and Disease 

Prevention (DEDP), is accepting 

applications for cooperative agreement 

for competitive supplemental funds to 

enhance activities in the Epidemiology 

Program for American Indian/Alaska 

Native (AI/AN) Tribes and Urban Indian 

communities. This program is 

authorized under: Section 317(k)(2) of 

the Public Health Service Act (42 U.S.C. 

Section 247b(k)), as amended. Funding 

for this award will be provided by: The 

Centers for Disease Control and 

Prevention’s (CDC) National Center for 

Chronic Disease Prevention and Health 

Promotion. The authorities will be 

exercised by CDC and through an IntraDepartmental Delegation of Authority 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 158 / Wednesday, August 15, 2018 / Notices 40533 

(IDDA) with IHS to create a 

supplemental funding opportunity for 

Tribal Epidemiology Centers. The 

administration will be carried out 

through an Intra-agency Agreement 

(IAA) between CDC and IHS. This 

program is described in the Catalog of 

Federal Domestic Assistance (CFDA) 

under 93.231. 

Background 

The Tribal Epidemiology Center (TEC) 

program was authorized by Congress in 

1998 as a way to provide public health 

support to multiple Tribes and Urban 

Indian communities in each of the IHS 

Areas. Only current TEC grantees are 

eligible to apply for the competing 

supplemental funding under this 

announcement and must demonstrate 

that they have complied with previous 

terms and conditions of the TEC 

program. 

TECs are uniquely positioned within 

Tribes, Tribal and Urban Indian 

organizations to conduct disease 

surveillance, research, prevention and 

control of disease, injury, or disability, 

and to assess the effectiveness of AI/AN 

public health programs. Positioned 

uniquely within Tribes and Tribal or 

Urban Organizations, TECs are able to 

conduct disease surveillance, research, 

prevention and control of disease, 

injury, or disability. This allows them to 

assess the effectiveness of AI/AN public 

health programs. In addition, they can 

fill gaps in data needed for the relevant 

Government Performance and Results 

Act and Healthy People 2020 measures. 

Some of the existing TECs have already 

developed innovative strategies to 

monitor the health status of Tribes and 

Urban Indian communities, including 

the development of Tribal health 

registries and use of sophisticated 

record linkage computer software to 

correct existing state data sets for racial 

misclassification. Tribal Epidemiology 

Centers work in partnership with IHS 

DEDP to provide a more accurate 

national picture of Indian health status. 

To further the goals of the partnership, 

a new CDC funding opportunity will be 

made available to TECs to implement 

cancer projects in Indian Country, 

designed to help decrease these 

disparities and lessen the burden of 

cancer in this population. For 

administrative purposes, this new 

funding opportunity will be packaged 

with the existing IHS cooperative 

agreements. 

The mission of the CDC National 

Center for Chronic Disease Prevention 

and Health Promotion is to help people 

and communities prevent chronic 

diseases and promote health and 

wellness for all. Within the National 

Center for Chronic Disease Prevention 

and Health Promotion, the Division of 

Cancer Prevention and Control (DCPC) 

works with national organizations, state 

and Tribal health agencies, and other 

key groups to develop, implement, and 

promote effective strategies for 

preventing and controlling cancer. 

Purpose 

The National Center for Chronic 

Disease Prevention and Health 

Promotion will be supporting two 

activities with funding from DCPC. The 

first, Colorectal Cancer Screening 

Among AI/AN with Diabetes, seeks to 

reduce a diabetes-linked cancer health 

disparity experienced by the AI/AN 

population. This population 

experiences the highest rates of diabetes 

in the United States. Despite the recent 

identification of diabetes as a significant 

risk factor for colorectal cancer (CRC), 

screening rates remain poor in the 

diabetic population. Consequently, 

there is a critical need for effective 

intervention that promotes both CRC 

risk awareness and screening among AI/ 

ANs with diabetes. 

The second National Center for 

Chronic Disease Prevention and Health 

Promotion activity, Annual Cancer 

Survivorship Group Leadership 

Training, seeks to increase cancer 

survivor support group leadership in 

AI/AN communities. 

This cooperative agreement is to 

support the following National Center 

for Chronic Disease Prevention and 

Health Promotion activities: 

(a) Colorectal Cancer Screening 

Among AI/AN with Diabetes. 

i. Develop a culturally grounded, 

multilevel intervention to communicate 

CRC risk and prevention information to 

AI/AN men and women over age 50 

who have diabetes. 

ii. Determine effectiveness of 

colorectal cancer screening through 

direct mailing fecal immunochemical 

test (FIT) kits to AI/AN patients with 

diabetes. 

iii. Develop a plan to embed CRC 

control initiatives within established 

diabetes management systems at Indian 

Health Service/Tribal health facilities. 

(b) Annual Cancer Survivorship 

Leadership Training. 

i. Organize and implement at least 

two, three-day cancer support 

leadership trainings for 15–25 AI/AN 

participants, nationally. The training 

will be designed to give participants a 

unique opportunity to work together in 

a safe, supportive environment to learn 

and practice skills to help people 

affected by cancer in their communities. 

The training will be based on the model, 

A Gathering of Cancer Support, using 

the Gathering of Native Americans 

(GONA) teaching methods. 

Limited Competition Justification 

The IHS enters into cooperative 

agreements with TECs under the 

authority of Section 214(a)(1) of the 

Indian Health Care Improvement Act, 

Public Law 94–437, as amended by 

Public Law 102–573. Tribal 

Epidemiology Centers carry out a list of 

functions specified in statute. These 

functions include data collection and 

analysis; evaluation of existing delivery 

systems, data systems, and other 

systems that impact the improvement of 

Indian health; making recommendations 

for the targeting of services; and 

provision of requested technical 

assistance to Indian Tribes, Tribal 

organizations, and Urban Indian 

organizations [25 U.S.C. 1621m(b)]. 

Other organizations do not have the 

capacity to provide this support. With 

respect to access to information, TECs 

are treated as public health authorities 

for the purposes of the Health Insurance 

Portability and Accountability Act of 

1996 (Pub L. 104–191). Unlike their 

counterparts, they have no (or little) 

funding from their jurisdictional 

governments to perform these public 

functions. 

The IHS and the CDC have 

determined that the TECs provide the 

most effective approach to strengthen 

public health capacity to support Tribes, 

Tribal organizations, and Urban Indian 

organizations, in identifying relevant 

health status indicators and priorities 

using sound epidemiologic principles. 

II. Award Information 

Type of Award 

Cooperative Agreement. 

Estimated Funds Available 

The total amount of funding 

identified for the current fiscal year (FY) 

2018 is approximately $220,000. An 

estimated $135,000 will be awarded for 

the National Center for Chronic Disease 

Prevention and Health Promotion 

Colorectal Cancer Screening Among 

American Indians with Diabetes 

activities, and, a total of $85,000 will be 

awarded for the National Center for 

Chronic Disease Prevention and Health 

Promotion Annual Cancer Survivorship 

Group Leadership Trainings. Individual 

award amounts are anticipated to be 

between $85,000 and $220,000. The 

amount of funding available for 

competing and continuation awards 

issued under this announcement are 

subject to the availability of 

appropriations and budgetary priorities 

of the CDC. The IHS is under no 


daltland on DSKBBV9HB2PROD with NOTICES
40534 Federal Register / Vol. 83, No. 158 / Wednesday, August 15, 2018 / Notices 

obligation to make awards that are 

selected for funding under this 

announcement. 

Anticipated Number of Awards 

Approximately two awards will be 

issued under this program 

announcement. 

Period of Performance 

The period of performance is for three 

years and will run consecutively from 

September 30, 2018 to September 29, 

2021. 

Cooperative Agreement 

Cooperative agreements awarded by 

the Department of Health and Human 

Services (HHS) are administered under 

the same policies as a grant. However, 

the funding agency (CDC) is required to 

have substantial programmatic 

involvement in the project during the 

entire award segment. Below is a 

detailed description of the level of 

involvement required for both the CDC 

and the grantee. The CDC, per the MOU 

between the IHS and the CDC, will be 

responsible for activities listed under 

section A and the grantee will be 

responsible for activities listed under 

section B as stated: 

Substantial Involvement Description for 

Cooperative Agreement 

A. CDC Programmatic Involvement 

(1) Provide funded TECs with ongoing 

consultation and technical assistance to 

plan, implement, and evaluate each 

component as described under 

Recipient Activities. Consultation and 

technical assistance may include, but 

not be limited to, the following areas: 

(i) Interpretation of current scientific 

literature related to epidemiology, 

statistics, surveillance, and other public 

health issues; 

(ii) Technical Assistance on the 

design and implementation of each 

program component such as 

surveillance, epidemiologic analysis, 

outbreak investigation, development of 

epidemiologic studies, development of 

disease control programs, and 

coordination of activities; and 

(iii) Technical Assistance on overall 

operational planning and program 

management. 

(2) Conduct routine site visits to TECs 

and/or coordinate TEC visits to IHS 

headquarters in order to assess work 

plans and ensure data security, confirm 

compliance with applicable laws and 

regulations, assess program activities, 

and to mutually resolve problems, as 

needed. 

B. Grantee Cooperative Agreement 

Award Activities 

(1) Provide a work plan to accomplish 

tasks described under National Center 

for Chronic Disease Prevention and 

Health Promotion Activities in the 

Purpose section. 

(2) Succinctly and independently 

address and report on the requirements 

for each funding stream awarded under 

Recipient Activities. Specifically: 

(i) Colorectal Cancer Screening 

Among American Indians with Diabetes. 

(a) Submit documentation of approval 

for the study/project from all necessary 

Institutional Review Boards (IRBs) 

including IHS, CDC, and Tribal (if 

applicable) prior to initiation of any 

study involving human subjects. 

(b) Coordinate testing of an 

innovative, multilevel intervention to 

promote fecal immunochemical testing 

(FIT) among American Indian men and 

women of or over age 50 who have 

diabetes. 

(c) Coordinate testing of the 

intervention model for feasibility and 

effectiveness to be carried out by four 

Tribal health programs, should such 

programs agree to participate. 

(ii) Annual Cancer Survivorship 

Group Leadership Training. 

(a) Work plan must include the 

training objectives, trainers, and the 

utilization of GONA training methods. 

The work plan must include an outline 

of outreach efforts to Tribal 

communities across the United States, 

not just with the TEC’s catchment area. 

The following should also be considered 

when planning the training: 

• Based on a grassroots approach, an 

order of preference for Tribal 

community members attending the 

training would be cancer survivors, 

family members of cancer survivors, 

Tribal health care workers, and others. 

The selection will be further based on 

the intention of the attendee and their 

plans for use of the training in their 

community. 

• To establish cancer support services 

in the Tribal community, it is suggested 

that two people from the same 

community attend the training together 

to assist each other in the future. 

• To reach as many Tribal 

communities and members as possible, 

each training should be limited to new 

participants. 

• Submit report describing the 

number of trainings that were 

conducted and how many participants 

attended each training. 

• Submit registration forms of 

attendees and their contact information 

for use in updating list of previous 

attendees. 

III. Eligibility Information 

1. Eligibility 

Only current TEC grantees are eligible 

to apply for the competing 

supplemental funding under this 

announcement and must demonstrate 

that they have complied with previous 

terms and conditions of the TEC 

program. 

Note: Please refer to Section IV.2 

(Application and Submission Information/ 

Subsection 2, Content and Form of 

Application Submission) for additional proof 

of applicant status documents required, such 

as proof of non-profit status, etc. 

2. Cost Sharing or Matching 

The IHS does not require matching 

funds or cost sharing for grants or 

cooperative agreements. 

3. Other Requirements 

If application budgets exceed the 

highest dollar amount outlined under 

the Estimated Funds Available section 

within this funding announcement, the 

application will be considered ineligible 

and will not be reviewed for further 

consideration. If deemed ineligible, IHS 

will not return the application. The 

applicant will be notified by email by 

the Division of Grants Management 

(DGM) of this decision. 

IV. Application and Submission 

Information 

1. Obtaining Application Materials 

The application package and detailed 

instructions for this announcement can 

be found at http://www.Grants.gov or 

http://www.ihs.gov/dgm/funding/. 

Questions regarding the electronic 

application process may be directed to 

Mr. Paul Gettys at (301) 443–2114 or 

(301) 443–5204. 

2. Content and Form Application 

Submission 

The applicant must include the 

project narrative as an attachment to the 

application package. Mandatory 

documents for all applicants include: 

• Table of contents. 

• Abstract (one page) summarizing 

the project. 

• Application forms: 

Æ SF–424, Application for Federal 

Assistance. 

Æ SF–424A, Budget Information— 

Non-Construction Programs. 

Æ SF–424B, Assurances—NonConstruction Programs. 

• Budget Justification and Narrative 

(must be single-spaced and not exceed 

5 pages). 

• Project Narrative (must be singlespaced and not exceed 10 pages). 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 158 / Wednesday, August 15, 2018 / Notices 40535 

Æ Background information on the 

organization. 

Æ Proposed scope of work, objectives, 

and activities that provide a description 

of what will be accomplished, including 

a one-page Timeframe Chart. 

• Letters of Support from 

organization’s Board of Directors. 

• 501(c)(3) Certificate (if applicable). 

• Biographical sketches for all Key 

Personnel. 

• Contractor or Consultant resumes or 

qualifications and scope of work. 

• Disclosure of Lobbying Activities 

(SF–LLL). 

• Certification Regarding Lobbying 

(GG-Lobbying Form). 

• Copy of current Negotiated Indirect 

Cost rate (IDC) agreement (required in 

order to receive IDC). 

• Organizational Chart (optional). 

• Documentation of current Office of 

Management and Budget (OMB) 

Financial Audit (if applicable). 

Acceptable forms of documentation 

include: 

Æ Email confirmation from Federal 

Audit Clearinghouse (FAC) that audits 

were submitted; or 

Æ Face sheets from audit reports. 

These can be found on the FAC website: 

https://harvester.census.gov/facdissem/ 

Main.aspx. 

Public Policy Requirements 

All Federal-wide public policies 

apply to IHS grants and cooperative 

agreements with exception of the 

Discrimination policy. 

Requirements for Project and Budget 

Narratives 

A. Project Narrative: This narrative 

should be a separate Word document 

that is no longer than 10 pages and 

must: Be single-spaced, type written, 

have consecutively numbered pages, use 

black type not smaller than 12 points, 

and be printed on one side only of 

standard size 81⁄2′′ × 11′′ paper. 

Be sure to succinctly answer all 

questions listed under the evaluation 

criteria (refer to Section V.1, Evaluation 

criteria in this announcement) and place 

all responses and required information 

in the correct section (noted below), or 

they will not be considered or scored. 

These narratives will assist the 

Objective Review Committee (ORC) in 

becoming familiar with the applicant’s 

activities and accomplishments prior to 

this possible cooperative agreement 

award. If the narrative exceeds the page 

limit, only the first 10 pages will be 

reviewed. The 10-page limit for the 

narrative does not include the work 

plan, standard forms, table of contents, 

budget, budget justifications, narratives, 

and/or other appendix items. 

There are three parts to the narrative: 

Part A—Program Information; Part B— 

Program Planning and Evaluation; and 

Part C—Program Report. See below for 

additional details about what must be 

included in the narrative. 

The page limitations below are for 

each narrative and budget submitted. 

Part A: Program Information (3 Pages) 

Section 1: Introduction and Need for 

Assistance 

Must include the applicant’s 

background information, a description 

of epidemiological service, 

epidemiological capacity and history of 

support for such activities. Applicants 

need to include current public health 

activities, what program services are 

currently being provided, and 

interactions with other public health 

authorities in the region (state, local, or 

Tribal). 

Section 2: Organizational Capabilities 

The applicant must describe staff 

capabilities or hiring plans for the key 

personnel with appropriate expertise in 

epidemiology, health sciences, and 

program management. The applicant 

must also demonstrate access to 

specialized expertise such as a doctoral 

level epidemiologist and/or a 

biostatistician. Applicants must include 

an organizational chart, and provide 

position descriptions and biographical 

sketches of key personnel including 

consultants or contractors. The position 

description should clearly describe each 

position and its duties. Resume should 

indicate that proposed staff is qualified 

to carry out the project activities. 

Section 3: User Population 

The number of AI/ANs served must 

be substantiated by documentation 

describing IHS user populations, United 

States Census Bureau data, clinical 

catchment data, or any method that is 

scientifically and epidemiologically 

valid. 

Part B: Program Planning and 

Evaluation (5 Pages) 

Section 1: Program Plans 

Applicant must include a workplan 

that describes program goals, objectives, 

activities, timeline, and responsible 

person for carrying out the objectives/ 

activities. The applicant must specify 

which activities listed under the 

Grantee Cooperative Agreement Award 

Activities are proposed. 

Section 2: Program Evaluation 

Applicant must define the criteria to 

be used to evaluate activities listed in 

the workplan under the Grantee 

Cooperative Agreement Award 

Activities. They must explain the 

methodology that will be used to 

determine if the needs identified for the 

objectives are being met and if the 

outcomes identified are being achieved 

and describe how evaluation findings 

will be disseminated to stakeholders. 

Part C: Program Report (2 Pages) 

Section 1: Describe your 

organization’s significant program 

activities and accomplishments over the 

past five years associated with the goals 

of this announcement. 

Section 2: Describe major activities 

over the last 24 months related to 

conducting applied research projects, 

training community health 

representatives, implementing quality 

improvement initiatives in IHS or Tribal 

healthcare facilities, and/or organizing 

cancer survivor group leadership 

trainings. 

B. Budget Narrative (5 Pages) 

This narrative must include a line 

item budget with a narrative 

justification for all expenditures 

identifying reasonable allowable, 

allocable costs necessary to accomplish 

the goals and objectives as outlined in 

the project narrative. Budget should 

match the scope of work described in 

the project narrative. 

3. Submission Dates and Times 

Applications must be submitted 

electronically through Grants.gov by 

11:59 p.m. Eastern Daylight Time (EDT) 

on the Application Deadline Date listed 

in the Key Dates section on page one of 

this announcement. Any application 

received after the application deadline 

will not be accepted for processing, nor 

will it be given further consideration for 

funding. Grants.gov will notify the 

applicant via email if the application is 

rejected. 

If technical challenges arise and 

assistance is required with the 

electronic application process, contact 

Grants.gov Customer Support via email 

to support@grants.gov or at (800) 518– 

4726. Customer Support is available to 

address questions 24 hours a day, 7 days 

a week (except on Federal holidays). If 

problems persist, contact Mr. Gettys 

(Paul.Gettys@ihs.gov), DGM Grant 

Systems Coordinator, by telephone at 

(301) 443–2114 or (301) 443–5204. 

Please contact Mr. Gettys at least ten 

days prior to the application deadline. 

Please do not contact the DGM until you 

have received a Grants.gov tracking 

number. In the event you are not able 

to obtain a tracking number, call the 

DGM as soon as possible. 


daltland on DSKBBV9HB2PROD with NOTICES
40536 Federal Register / Vol. 83, No. 158 / Wednesday, August 15, 2018 / Notices 

4. Intergovernmental Review 

Executive Order 12372 requiring 

intergovernmental review is not 

applicable to this program. 

5. Funding Restrictions 

• Pre-award costs are not allowable. 

• The available funds are inclusive of 

direct and appropriate indirect costs. 

• Only one grant/cooperative 

agreement will be awarded per 

applicant. 

• IHS will not acknowledge receipt of 

applications. 

6. Electronic Submission Requirements 

All applications must be submitted 

electronically. Please use the http://

www.Grants.gov website to submit an 

application electronically and select the 

‘‘Search Grants’’ link on the homepage. 

Follow the instructions for submitting 

an application under the Package tab. 

Electronic copies of the application may 

not be submitted as attachments to 

email messages addressed to IHS 

employees or offices. 

Waiver Request 

If the applicant needs to submit a 

paper application instead of submitting 

electronically through Grants.gov, a 

waiver must be requested. Prior 

approval must be requested and 

obtained from Mr. Robert Tarwater, 

Director, DGM, (see Section IV.6 below 

for additional information). A written 

waiver request must be sent to 

GrantsPolicy@ihs.gov with a copy to 

Robert.Tarwater@ihs.gov. The waiver 

must: (1) Be documented in writing 

(emails are acceptable), before 

submitting a paper application, and (2) 

include clear justification for the need 

to deviate from the required electronic 

grants submission process. 

Once the waiver request has been 

approved, the applicant will receive a 

confirmation of approval email 

containing submission instructions and 

the mailing address to submit the 

application. A copy of the written 

approval must be submitted along with 

the hardcopy of the application that is 

mailed to DGM. Paper applications that 

are submitted without a copy of the 

signed waiver from the Director of the 

DGM will not be reviewed or considered 

for funding. The applicant will be 

notified via email of this decision by the 

Grants Management Officer of the DGM. 

Paper applications must be received by 

the DGM no later than 5:00 p.m., EDT, 

on the Application Deadline Date listed 

in the Key Dates section on page one of 

this announcement. Late applications 

will not be accepted for processing or 

considered for funding. Applicants that 

do not adhere to the timelines for 

System for Award Management (SAM) 

and/or http://www.Grants.gov 

registration or that fail to request timely 

assistance with technical issues will not 

be considered for a waiver to submit a 

paper application. 

Please be aware of the following: 

• Please search for the application 

package in http://www.Grants.gov by 

entering the CFDA number or the 

Funding Opportunity Number. Both 

numbers are located in the header of 

this announcement. 

• If you experience technical 

challenges while submitting your 

application electronically, please 

contact Grants.gov Support directly at: 

support@grants.gov or (800) 518–4726. 

Customer Support is available to 

address questions 24 hours a day, 7 days 

a week (except on Federal holidays). 

• Upon contacting Grants.gov, obtain 

a tracking number as proof of contact. 

The tracking number is helpful if there 

are technical issues that cannot be 

resolved and a waiver from the agency 

must be obtained. 

• Applicants are strongly encouraged 

not to wait until the deadline date to 

begin the application process through 

Grants.gov as the registration process for 

SAM and Grants.gov could take up to 

fifteen working days. 

• Please use the optional attachment 

feature in Grants.gov to attach 

additional documentation that may be 

requested by the DGM. 

• All applicants must comply with 

any page limitation requirements 

described in this funding 

announcement. 

• After electronically submitting the 

application, the applicant will receive 

an automatic acknowledgment from 

Grants.gov that contains a Grants.gov 

tracking number. The DGM will 

download the application from 

Grants.gov and provide necessary copies 

to the appropriate agency officials. 

Neither the DGM nor the Division of 

Epidemiology and Disease Prevention 

will notify the applicant that the 

application has been received. 

• Email applications will not be 

accepted under this announcement. 

Dun and Bradstreet (D&B) Data 

Universal Numbering System (DUNS) 

All IHS applicants and grantee 

organizations are required to obtain a 

DUNS number and maintain an active 

registration in the SAM database. The 

DUNS number is a unique 9-digit 

identification number provided by D&B 

which uniquely identifies each entity. 

The DUNS number is site specific; 

therefore, each distinct performance site 

may be assigned a DUNS number. 

Obtaining a DUNS number is easy, and 

there is no charge. To obtain a DUNS 

number, you may access it through 

http://fedgov.dnb.com/webform, or to 

expedite the process, call (866) 705– 

5711. 

All HHS recipients are required by the 

Federal Funding Accountability and 

Transparency Act of 2006, as amended 

(‘‘Transparency Act’’), to report 

information on sub-awards. 

Accordingly, all IHS grantees must 

notify potential first-tier sub-recipients 

that no entity may receive a first-tier 

sub-award unless the entity has 

provided its DUNS number to the prime 

grantee organization. This requirement 

ensures the use of a universal identifier 

to enhance the quality of information 

available to the public pursuant to the 

Transparency Act. 

System for Award Management (SAM) 

Organizations that were not registered 

with Central Contractor Registration and 

have not registered with SAM will need 

to obtain a DUNS number first and then 

access the SAM online registration 

through the SAM home page at https:// 

www.sam.gov (U.S. organizations will 

also need to provide an Employer 

Identification Number from the Internal 

Revenue Service that may take an 

additional 2–5 weeks to become active). 

Completing and submitting the 

registration takes approximately one 

hour to complete and SAM registration 

will take 3–5 business days to process. 

Registration with the SAM is free of 

charge. Applicants may register online 

at https://www.sam.gov. 

Additional information on 

implementing the Transparency Act, 

including the specific requirements for 

DUNS and SAM, can be found on the 

IHS Grants Management, Grants Policy 

website: http://www.ihs.gov/dgm/ 

policytopics/. 

V. Application Review Information 

The instructions for preparing the 

application narrative also constitute the 

evaluation criteria for reviewing and 

scoring the application. Weights 

assigned to each section are noted in 

parentheses. The 10 page narrative 

should include only the first year of 

activities; information for multi-year 

projects should be included as an 

appendix. See ‘‘Multi-year Project 

Requirements’’ at the end of this section 

for more information. The narrative 

section should be written in a manner 

that is clear to outside reviewers 

unfamiliar with prior related activities 

of the applicant. It should be well 

organized, succinct, and contain all 

information necessary for reviewers to 

understand the project fully. Points will 

be assigned to each evaluation criteria 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 158 / Wednesday, August 15, 2018 / Notices 40537 

adding up to a total of 100 points. A 

minimum score of 65 points is required 

for funding. Points are assigned as 

follows: 

1. Criteria 

A. Introduction and Need for Assistance 

(25 Points) 

(1) Describe the applicant’s current 

public health activities, including 

programs or services currently provided, 

interactions with other public health 

authorities in the regions (state, local, or 

Tribal) and how long the organization 

has been operating. Specifically 

describe the organization’s current 

capacity to conduct applied research 

projects, train community health 

representatives, implement quality 

improvement initiatives, and/or 

organize cancer survivor group 

leadership trainings and provide 

examples of implementing these 

activities. 

(2) Provide a physical location of the 

TEC and area to be served by the 

proposed program including a map 

(include the map in the attachments), 

and specifically describe the office 

space and how it is going to be paid for. 

(3) Describe the applicant’s user 

population. The applicant must 

demonstrate AI/ANs will be served and 

must be substantiated by documentation 

describing IHS user populations, United 

States Census Bureau data, clinical 

catchment data, or any method that is 

scientifically and epidemiologically 

valid. 

B. Project Objective(s), Work Plan and 

Approach (45 Points) 

(1) State in measurable and realistic 

terms the objectives and appropriate 

activities to achieve each objective for 

the projects under the Substantial 

Involvement Description for 

Cooperative Agreement, Section B. 

Grantee Cooperative Agreement Award 

Activities located on page 8. 

(2) Identify the expected results, 

benefits, and outcomes or products to be 

derived from each objective of the 

project. 

(3) Include a work-plan for each 

objective that indicates when the 

objectives and major activities will be 

accomplished and who will conduct the 

activities. 

C. Program Evaluation (10 Points) 

(1) Define the criteria to be used to 

evaluate activities listed in the workplan under the Substantial Involvement 

Description for Cooperative Agreement, 

Section B. Grantee Cooperative 

Agreement Award Activities located on 

page 8. 

(2) Explain the methodology that will 

be used to determine if the needs 

identified for the objectives are being 

met and if the outcomes identified are 

being achieved. 

(3) Describe how evaluation findings 

will be disseminated to stakeholders, 

including the Indian Health Service. 

D. Organizational Capabilities, Key 

Personnel and Qualifications (15 Points) 

(1) Explain both the management and 

administrative structure of the 

organization including documentation 

of current certified financial 

management systems from the Bureau of 

Indian Affairs, IHS, or a Certified Public 

Accountant and an updated 

organizational chart (include in 

appendix). 

(2) Describe the ability of the 

organization to manage a program of the 

proposed scope. 

(3) Provide position descriptions and 

biographical sketches of key personnel, 

including those of consultants or 

contractors in the Appendix. Position 

descriptions should very clearly 

describe each position and its duties, 

indicating desired qualification and 

experience requirements related to the 

project. Resumes should indicate that 

the proposed staff is qualified to carry 

out the project activities. Applicants 

with expertise in epidemiology will 

receive priority. 

E. Categorical Budget and Budget 

Justification (5 Points) 

(1) The five points for Categorical 

Budget only applies to Year 1. Provide 

a line item budget and budget narrative 

for Year 1. 

(2) Provide a justification by line item 

in the budget including sufficient cost 

and other details to facilitate the 

determination of cost allowance and 

relevance of these costs to the proposed 

project. The funds requested should be 

appropriate and necessary for the scope 

of the project. 

(3) If use of consultants or contractors 

are proposed or anticipated, provide a 

detailed budget and scope of work that 

clearly defines the deliverables or 

outcomes anticipated. 

(4) Applicant is encouraged to submit 

a line item budget and budget narrative 

by category for years 2–3 as an appendix 

to show the three-year plan of the 

proposal. 

Multi-Year Project Requirements 

Projects requiring a second, or third 

year must include a brief project 

narrative and budget (one additional 

page per year) addressing the 

developmental plans for each additional 

year of the project. 

Additional Documents Can be Uploaded 

as Appendix Items in Grants.gov 

• Work plan, logic model and/or time 

line for proposed objectives. 

• Position descriptions for key staff. 

• Resumes of key staff that reflect 

current duties. 

• Consultant or contractor proposed 

scope of work and letter of commitment 

(if applicable). 

• Current Indirect Cost Agreement. 

• Organizational chart. 

• Map of area identifying project 

location(s). 

• Additional documents to support 

narrative (i.e., data tables, key news 

articles, etc.). 

2. Review and Selection 

Each application will be prescreened 

by the DGM staff for eligibility and 

completeness as outlined in the funding 

announcement. Applications that meet 

the eligibility criteria shall be reviewed 

for merit by the ORC based on 

evaluation criteria in this funding 

announcement. The ORC could be 

composed of both Tribal and Federal 

reviewers appointed by the IHS Program 

to review and make recommendations 

on these applications. The technical 

review process ensures selection of 

quality projects in a national 

competition for limited funding. 

Incomplete applications and 

applications that are non-responsive to 

the eligibility criteria will not be 

referred to the ORC. The applicant will 

be notified via email of this decision by 

the Grants Management Officer of the 

DGM. Applicants will be notified by 

DGM, via email, regarding minor 

missing components (i.e., budget 

narratives, audit documentation, key 

contact form) needed for an otherwise 

complete application. All missing 

documents must be sent to DGM on or 

before the due date listed in the email 

of notification of missing documents 

required. 

To obtain a minimum score for 

funding by the ORC, applicants must 

address all program requirements and 

provide all required documentation. 

VI. Award Administration Information 

1. Award Notices 

The Notice of Award (NoA) is a 

legally binding document signed by the 

Grants Management Officer and serves 

as the official notification of the grant 

award. The NoA will be initiated by the 

DGM in our grant system, 

GrantSolutions (https://

www.grantsolutions.gov). Each entity 

that is approved for funding under this 

announcement will need to request or 

have a user account in GrantSolutions 


daltland on DSKBBV9HB2PROD with NOTICES
40538 Federal Register / Vol. 83, No. 158 / Wednesday, August 15, 2018 / Notices 

in order to retrieve their NoA. The NoA 

is the authorizing document for which 

funds are dispersed to the approved 

entities and reflects the amount of 

Federal funds awarded, the purpose of 

the grant, the terms and conditions of 

the award, the effective date of the 

award, and the budget and project 

period. 

Disapproved Applicants 

Applicants who received a score less 

than the recommended funding level for 

approval, 65, and were deemed to be 

disapproved by the ORC, will receive an 

Executive Summary Statement from the 

IHS program office within 30 days of the 

conclusion of the ORC outlining the 

strengths and weaknesses of their 

application. The summary statement 

will be sent to the Authorized 

Organizational Representative that is 

identified on the face page (SF–424) of 

the application. The IHS program office 

will also provide additional contact 

information as needed to address 

questions and concerns as well as 

provide technical assistance if desired. 

Approved But Unfunded Applicants 

Approved but unfunded applicants 

that met the minimum scoring range 

and were deemed by the ORC to be 

‘‘Approved,’’ but were not funded due 

to lack of funding, will have their 

applications retained by DGM for a 

period of one year. If additional funding 

becomes available during the course of 

FY 2018 the approved but unfunded 

application may be re-considered by the 

awarding program office for possible 

funding. The applicant will also receive 

an Executive Summary Statement from 

the IHS program office within 30 days 

of the conclusion of the ORC. 

Note: Any correspondence other than the 

official NoA signed by an IHS grants 

management official announcing to the 

project director that an award has been made 

to their organization is not an authorization 

to implement their program on behalf of IHS. 

2. Administrative Requirements 

Cooperative agreements are 

administered in accordance with the 

following regulations and policies: 

A. The criteria as outlined in this 

program announcement. 

B. Administrative Regulations for 

Grants: 

• Uniform Administrative 

Requirements for HHS Awards, located 

at 45 CFR part 75. 

C. Grants Policy: 

• HHS Grants Policy Statement, 

Revised 01/07. 

D. Cost Principles: 

• Uniform Administrative 

Requirements for HHS Awards, ‘‘Cost 

Principles,’’ located at 45 CFR part 75, 

subpart E. 

E. Audit Requirements: 

• Uniform Administrative 

Requirements for HHS Awards, ‘‘Audit 

Requirements,’’ located at 45 CFR part 

75, subpart F. 

3. Indirect Costs 

This section applies to all grant 

recipients that request reimbursement of 

indirect costs (IDC) in their grant 

application. In accordance with HHS 

Grants Policy Statement, Part II–27, IHS 

requires applicants to obtain a current 

IDC rate agreement prior to award. The 

rate agreement must be prepared in 

accordance with the applicable cost 

principles and guidance as provided by 

the cognizant agency or office. A current 

rate covers the applicable grant 

activities under the current award’s 

budget period. If the current rate is not 

on file with the DGM at the time of 

award, the IDC portion of the budget 

will be restricted. The restrictions 

remain in place until the current rate is 

provided to the DGM. 

Generally, IDC rates for IHS grantees 

are negotiated with the Division of Cost 

Allocation (DCA) https://rates.psc.gov/ 

and the Department of Interior (Interior 

Business Center) https://www.doi.gov/ 

ibc/services/finance/indirect-CostServices/indian-tribes. For questions 

regarding the indirect cost policy, please 

call the Grants Management Specialist 

listed under ‘‘Agency Contacts’’ or the 

main DGM office at (301) 443–5204. 

4. Reporting Requirements 

The grantee must submit required 

reports consistent with the applicable 

deadlines. Failure to submit required 

reports within the time allowed may 

result in suspension or termination of 

an active grant, withholding of 

additional awards for the project, or 

other enforcement actions such as 

withholding of payments or converting 

to the reimbursement method of 

payment. Continued failure to submit 

required reports may result in one or 

both of the following: (1) The 

imposition of special award provisions; 

and (2) the non-funding or non-award of 

other eligible projects or activities. This 

requirement applies whether the 

delinquency is attributable to the failure 

of the grantee organization or the 

individual responsible for preparation 

of the reports. Per DGM policy, all 

reports are required to be submitted 

electronically by attaching them as a 

‘‘Grant Note’’ in GrantSolutions. 

Personnel responsible for submitting 

reports will be required to obtain a login 

and password for GrantSolutions. Please 

see the Agency Contacts list in Section 

VII for the systems contact information. 

The reporting requirements for this 

program are noted below. 

A. Progress Reports 

Program progress reports are required 

annually, within 30 days after the 

budget period ends. These reports must 

include a brief comparison of actual 

accomplishments to the goals 

established for the period, a summary of 

progress to date or, if applicable, 

provide sound justification for the lack 

of progress, and other pertinent 

information as required. A final report 

must be submitted within 90 days of the 

expiration of the period of performance. 

B. Financial Reports 

Federal Financial Report (FFR or SF– 

425), Cash Transaction Reports are due 

30 days after the close of every calendar 

quarter to the Payment Management 

Services, HHS at https://pms.psc.gov. It 

is recommended that the applicant also 

send a copy of the FFR (SF–425) report 

to the Grants Management Specialist. 

Failure to submit timely reports may 

cause a disruption in timely payments 

to the organization. 

Grantees are responsible and 

accountable for accurate information 

being reported on all required reports: 

The Progress Reports and Federal 

Financial Report. 

C. Federal Sub-Award Reporting System 

(FSRS) 

This award may be subject to the 

Transparency Act sub-award and 

executive compensation reporting 

requirements of 2 CFR part 170. 

The Transparency Act requires the 

OMB to establish a single searchable 

database, accessible to the public, with 

information on financial assistance 

awards made by Federal agencies. The 

Transparency Act also includes a 

requirement for recipients of Federal 

grants to report information about firsttier sub-awards and executive 

compensation under Federal assistance 

awards. 

IHS has implemented a Term of 

Award into all IHS Standard Terms and 

Conditions, NoAs and funding 

announcements regarding the FSRS 

reporting requirement. This IHS Term of 

Award is applicable to all IHS grant and 

cooperative agreements issued on or 

after October 1, 2010, with a $25,000 

sub-award obligation dollar threshold 

met for any specific reporting period. 

Additionally, all new (discretionary) 

IHS awards (where the period of 

performance is made up of more than 

one budget period) and where: (1) The 

period of performance start date was 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 158 / Wednesday, August 15, 2018 / Notices 40539 

October 1, 2010 or after, and (2) the 

primary awardee will have a $25,000 

sub-award obligation dollar threshold 

during any specific reporting period 

will be required to address the FSRS 

reporting. 

For the full IHS award term 

implementing this requirement and 

additional award applicability 

information, visit the DGM Grants 

Policy website at http://www.ihs.gov/ 

dgm/policytopics/. 

D. Compliance With Executive Order 

13166 Implementation of Services 

Accessibility Provisions for All Grant 

Application Packages and Funding 

Opportunity Announcements 

Recipients of Federal financial 

assistance (FFA) from HHS must 

administer their programs in 

compliance with Federal civil rights 

law. This means that recipients of HHS 

funds must ensure equal access to their 

programs without regard to a person’s 

race, color, national origin, disability, 

age and, in some circumstances, sex and 

religion. This includes ensuring your 

programs are accessible to persons with 

limited English proficiency. HHS 

provides guidance to recipients of FFA 

on meeting their legal obligation to take 

reasonable steps to provide meaningful 

access to their programs by persons with 

limited English proficiency. Please see 

http://www.hhs.gov/civil-rights/forindividuals/special-topics/limitedenglish-proficiency/guidance-federalfinancial-assistance-recipients-title-VI/. 

The HHS Office for Civil Rights (OCR) 

also provides guidance on complying 

with civil rights laws enforced by HHS. 

Please see http://www.hhs.gov/civilrights/for-individuals/section-1557/ 

index.html; and http://www.hhs.gov/ 

civil-rights/index.html. Recipients of 

FFA also have specific legal obligations 

for serving qualified individuals with 

disabilities. Please see http://

www.hhs.gov/civil-rights/forindividuals/disability/index.html. 

Please contact the HHS OCR for more 

information about obligations and 

prohibitions under Federal civil rights 

laws at https://www.hhs.gov/ocr/aboutus/contact-us/index.html or call (800) 

368–1019 or TDD (800) 537–7697. Also 

note it is an HHS Departmental goal to 

ensure access to quality, culturally 

competent care, including long-term 

services and supports, for vulnerable 

populations. For further guidance on 

providing culturally and linguistically 

appropriate services, recipients should 

review the National Standards for 

Culturally and Linguistically 

Appropriate Services in Health and 

Health Care at https://

minorityhealth.hhs.gov/omh/ 

browse.aspx?lvl=2&lvlid=53. 

Pursuant to 45 CFR 80.3(d), an 

individual shall not be deemed 

subjected to discrimination by reason of 

his or her exclusion from benefits 

limited by Federal law to individuals 

eligible for benefits and services from 

the IHS. Recipients will be required to 

sign the HHS–690 Assurance of 

Compliance form which can be obtained 

from the following website: http://

www.hhs.gov/sites/default/files/forms/ 

hhs-690.pdf, and send it directly to the: 

U.S. Department of Health and Human 

Services, Office of Civil Rights, 200 

Independence Ave. SW, Washington, 

DC 20201. 

E. Federal Awardee Performance and 

Integrity Information System (FAPIIS) 

The IHS is required to review and 

consider any information about the 

applicant that is in the Federal Awardee 

Performance and Integrity Information 

System (FAPIIS) before making any 

award in excess of the simplified 

acquisition threshold (currently 

$150,000) over the period of 

performance. An applicant may review 

and comment on any information about 

itself that a Federal awarding agency 

previously entered. IHS will consider 

any comments by the applicant, in 

addition to other information in FAPIIS 

in making a judgment about the 

applicant’s integrity, business ethics, 

and record of performance under 

Federal awards when completing the 

review of risk posed by applicants as 

described in 45 CFR 75.205. 

As required by 45 CFR part 75 

Appendix XII of the Uniform Guidance, 

non-federal entities (NFEs) are required 

to disclose in FAPIIS any information 

about criminal, civil, and administrative 

proceedings, and/or affirm that there is 

no new information to provide. This 

applies to NFEs that receive Federal 

awards (currently active grants, 

cooperative agreements, and 

procurement contracts) greater than 

$10,000,000 for any period of time 

during the period of performance of an 

award/project. 

Mandatory Disclosure Requirements 

As required by 2 CFR part 200 of the 

Uniform Guidance, and the HHS 

implementing regulations at 45 CFR part 

75, effective January 1, 2016, the IHS 

must require a non-Federal entity or an 

applicant for a Federal award to 

disclose, in a timely manner, in writing 

to the IHS or pass-through entity all 

violations of Federal criminal law 

involving fraud, bribery, or gratuity 

violations potentially affecting the 

Federal award. 

Submission is required for all 

applicants and recipients, in writing, to 

the IHS and to the HHS Office of 

Inspector General all information 

related to violations of Federal criminal 

law involving fraud, bribery, or gratuity 

violations potentially affecting the 

Federal award. 45 CFR 75.113. 

Disclosures must be sent in writing to: 

U.S. Department of Health and Human 

Services, Indian Health Service, 

Division of Grants Management, Attn: 

Robert Tarwater, Director, 5600 Fishers 

Lane, Mail Stop: 09E70, Rockville, MD 

20857, (Include ‘‘Mandatory Grant 

Disclosures’’ in subject line). Office: 

(301) 443–5204, Fax: (301) 594–0899, 

Email: Robert.Tarwater@ihs.gov AND 

U.S. Department of Health and Human 

Services, Office of Inspector General, 

Attn: Mandatory Grant Disclosures, 

Intake Coordinator, 330 Independence 

Avenue SW, Cohen Building, Room 

5527, Washington, DC 20201, URL: 

http://oig.hhs.gov/fraud/report-fraud/ 

index.asp (Include ‘‘Mandatory Grant 

Disclosures’’ in subject line). Fax: (202) 

205–0604 (Include ‘‘Mandatory Grant 

Disclosures’’ in subject line) or Email: 

MandatoryGranteeDisclosures@

oig.hhs.gov. 

Failure to make required disclosures 

can result in any of the remedies 

described in 45 CFR 75.371. Remedies 

for noncompliance, including 

suspension or debarment (See 2 CFR 

parts 180 and 376 and 31 U.S.C. 3321). 

VII. Agency Contacts 

1. Questions on the programmatic 

issues may be directed to: Lisa C. Neel, 

Public Health Advisor, Office of Public 

Health Support, Division of 

Epidemiology & Disease Prevention, 

Indian Health Service, 5600 Fishers 

Lane, Mailstop: 09E17B, Rockville, MD 

20857, Phone: (301) 443–4305, Email: 

Lisa.Neel@ihs.gov. 

2. Questions on grants management 

and fiscal matters may be directed to: 

John Hoffman, Senior Grants 

Management Specialist, 5600 Fishers 

Lane, Mail Stop: 09E70, Rockville, MD 

20857, Phone: (301) 443–2116, Fax: 

(301) 594–0899, Email: John.Hoffman@

ihs.gov. 

3. Questions on systems matters may 

be directed to: Paul Gettys, Grant 

Systems Coordinator, 5600 Fishers 

Lane, Mail Stop: 09E70, Rockville, MD 

20857, Phone: (301) 443–2114; or the 

DGM main line (301) 443–5204, Fax: 

(301) 594–0899, Email: Paul.Gettys@

ihs.gov. 

VIII. Other Information 

The Public Health Service strongly 

encourages all cooperative agreement 

and contract recipients to provide a 


daltland on DSKBBV9HB2PROD with NOTICES
40540 Federal Register / Vol. 83, No. 158 / Wednesday, August 15, 2018 / Notices 

smoke-free workplace and promote the 

non-use of all tobacco products. In 

addition, Public Law 103–227, the ProChildren Act of 1994, prohibits smoking 

in certain facilities (or in some cases, 

any portion of the facility) in which 

regular or routine education, library, 

day care, health care, or early childhood 

development services are provided to 

children. This is consistent with the 

HHS mission to protect and advance the 

physical and mental health of the 

American people. 

Dated: August 10, 2018. 

Michael D. Weahkee, 

RADM, Assistant Surgeon General, U.S. 

Public Health Service, Acting Director, Indian 

Health Service. 

[FR Doc. 2018–17564 Filed 8–14–18; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Initial Review Group; Mental 

Health Services Research Committee. 

Date: October 15, 2018. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street NW, Washington, DC 20037. 

Contact Person: Aileen Schulte, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6136, MSC 9606, 

Bethesda, MD 20852, 301–443–1225, 

aschulte@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: August 9, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–17474 Filed 8–14–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel NIAID; Clinical Trial 

Planning Grant (R34). 

Date: September 5, 2018. 

Time: 10:00 a.m. to 11:30 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892. 

(Telephone Conference Call). 

Contact Person: Ellen S. Buczko, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

Room # 3F30A, National Institutes of Health/ 

NIAID, 5601 Fishers Lane, MSC 9823, 

Bethesda, MD 20892–9823, (240) 669–5028, 

ebuczko1@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel NIAID; Clinical Trial 

Planning Grant (R34). 

Date: September 5, 2018. 

Time: 1:00 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892, 

(Telephone Conference Call). 

Contact Person: Ellen S. Buczko, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

Room # 3F30A, National Institutes of Health/ 

NIAID, 5601 Fishers Lane, MSC 9823, 

Bethesda, MD 20892–9823, (240) 669–5028, 

ebuczko1@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: August 9, 2018. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–17477 Filed 8–14–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Special 

Topic in Nephrology. 

Date: August 22, 2018. 

Time: 2:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Atul Sahai, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2188, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1198, sahaia@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 9, 2018. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–17472 Filed 8–14–18; 8:45 am] 

BILLING CODE 4140–01–P 


daltland on DSKBBV9HB2PROD with NOTICES